Previous meta-analyses [51, 52, 53] have shown that SGLT-2 inhibitors and GLP1RAsexert positive effects on the prognosis of HF in both diabetic and non-diabeticpatients. The gene discussed is SLC5A2; the disease is hydrops fetalis.